§ 13F · FUND PROFILE
Propel Bio Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $82.4T (13F)Positions · 16Turnover · — · Q4Filed · Feb 11, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$20.4T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 11, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | 1.27M | $24.4T | 20.8% | ±0% |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | 3.79M | $18.8T | 16.1% | ±0% |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | 741K | $12.3T | 10.5% | +34% |
| 4 | VRDN | VIRIDIAN THERAPEUTICS INC | 283K | $8.8T | 7.5% | +214% |
| 5 | MIST | MILESTONE PHARMACEUTICALS | 4.12M | $8.3T | 7.1% | −20% |
| 6 | KYTX | KYVERNA THERAPEUTICS INC | 667K | $6.3T | 5.4% | NEW |
| 7 | CMPS | COMPASS PATHWAYS PLC | 862K | $5.9T | 5.1% | +69% |
| 8 | IVA | INVENTIVA SA - ADR | 1.00M | $4.7T | 4.0% | NEW |
| 9 | DCTH | DELCATH SYSTEMS INC | 439K | $4.4T | 3.8% | ±0% |
| 10 | ABEO | ABEONA THERAPEUTICS INC | 831K | $4.4T | 3.7% | −15% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PROPEL SIGNAL
AC read
Propel Bio Management, LLC is a Other fund managing $82391.7 trillion in assets. The fund runs a focused portfolio of just 16 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed